Rapid Blood-Type Test

Researchers describe a paper-based blood test that can determine a person’s blood type in just two minutes.

By | March 16, 2017

WIKIMEDIA, MARGRETTE DOMWhile existing tests can take anywhere from 5 to 20 minutes and require two steps to complete, a new paper-based diagnostic method, described in a paper published yesterday (March 15) in Science Translational Medicine, takes just 30 seconds to reveal whether a person is type A, B, or O, and a total of two minutes to reveal a whether the person is “positive” or “negative” for Rh factor, all with just one step.

Traditionally, blood typing requires forward typing, in which antibodies found in type A and type B blood are added to a blood sample to test for reactivity, followed by reverse typing, in which serum (cell-free blood) is mixed with the blood type identified in the first test. This stepwise process requires the separation of the serum using a filter—a procedure best carried out in a laboratory setting—and because the steps must be conducted consecutively, the whole process can take up to 20 minutes.

The new test, on the other hand, uses a paper strip that is coated in antibodies that recognize antigens found in different blood types, plus a commonly used green dye. When a drop of blood is put on the strip, it is wicked through the different types of antibody, turning squares either teal (if the antigen is present) or brown (if it’s not).

Hong Zhang of Third Military Medical University in Chongqing, China, and colleagues analyzed more than 3,500 blood samples with their paper strip with more than 99.9 percent accuracy, according to the study. In addition to being faster and more cost-effective in traditional settings, the test’s ease of use could prove invaluable for remote areas or war zones, where typically O blood (the “universal donor” type) is given because blood-type testing is impractical, Zhang told New Scientist. “We are expecting that we can see this product in the market within 1-2 years.”

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Human Cord Plasma Protein Boosts Cognitive Function in Older Mice
AAAS